We are live on
!
Find out more
BCM
Bratton Capital Management Portfolio holdings
AUM
$40.7M
1-Year Est. Return
43.1%
This Fund
S&P 500
This Quarter
Est. Return
-49.81%
1 Year Est. Return
+43.1%
3 Year Est. Return
+264.04%
5 Year Est. Return
-20.19%
10 Year Est. Return
–
AUM
$95.4M
AUM Growth
–
Cap. Flow
+$165M
Cap. Flow
% of AUM
173.28%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aquestive Therapeutics
AQST
|
+$145M |
| 2 |
Denali Therapeutics
DNLI
|
+$20.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SCM
VI
CPCM
CIC
LSA
SIM
CF
ICP
Bratton Capital Management's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Bratton Capital Management, which disclosed 2 positions worth $95.4M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Aquestive Therapeutics: 11,503,294 shares worth $72.5M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Bratton Capital Management's largest Q4 2018 buy was Aquestive Therapeutics: 11,503,294 shares worth $72.5M.
- Bratton Capital Management's ten largest holdings make up 100% of its $95.4M portfolio in Q4 2018.
- Bratton Capital Management disclosed 2 positions in Q4 2018, its first 13F filing on record.
Based on Bratton Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.